{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:18:02Z","timestamp":1793992682516,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Increased expression of the homodimeric S100A8 (A8) and S100A9 (A9) alarmins and their Calprotectin (CP) antimicrobial hetero-complex has been reported in Inflammatory Skin Diseases (ISDs) such as Atopic Dermatitis (AD), but the functional consequences of this increase are not known. We evaluated the cell- and tissue-specific functions of A8 and A9 in the local and the extra-cutaneous manifestations of ISD using genetically engineered mouse models. The genes encoding for the A9 or A8 proteins were inactivated in epidermal cells or neutrophils in the\n                    <jats:italic>JunB<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2206ep<\/jats:italic>\n                    <\/jats:sup>\n                    genetic mouse model for AD. Overall, epidermal inactivation of\n                    <jats:italic>A9<\/jats:italic>\n                    aggravated, while similar\n                    <jats:italic>A8<\/jats:italic>\n                    inactivation ameliorated experimental ISD. Epidermal differentiation and skin inflammation was also ameliorated when\n                    <jats:italic>A9<\/jats:italic>\n                    was inactivated in neutrophils or in all cells. However, complete\n                    <jats:italic>A9<\/jats:italic>\n                    knock-out was associated with worsened systemic effects, such as neutrophilic inflammation and bone loss. In addition, the distal phalanges of the digits displayed increased A8 protein expression, SA overgrowth and bone destruction. Epidermal\n                    <jats:italic>A8<\/jats:italic>\n                    inactivation ameliorated bone loss, but promoted bone destruction in the digits, likely through A8-positive neutrophilic infiltrates. These data show that site- and cell-type-specific A8 and A9 expression modulates chronic skin and systemic inflammation with distinct effects on the skin differentiation and on the musculoskeletal system. These findings pave the way for novel therapies targeting the divergent functions of A8 and A9 to restore epidermal homeostasis and prevent systemic complications.\n                  <\/jats:p>","DOI":"10.1038\/s41418-025-01504-9","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:35:36Z","timestamp":1744367736000},"page":"1833-1844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-8343","authenticated-orcid":false,"given":"Marta","family":"Palomo-Irigoyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6300-2420","authenticated-orcid":false,"given":"Latifa","family":"Bakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hendrikx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Hayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Schaffenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Widder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bachg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Starkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-8348","authenticated-orcid":false,"given":"Johannes","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-0196","authenticated-orcid":false,"given":"Erwin F.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"1504_CR1","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/jid.2013.446","volume":"134","author":"RJ Hay","year":"2014","unstructured":"Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527\u201334.","journal-title":"J Invest Dermatol"},{"key":"1504_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","volume":"153","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol. 2017;153:406\u201312.","journal-title":"JAMA Dermatol"},{"key":"1504_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345\u201360.","journal-title":"Lancet"},{"key":"1504_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","volume":"4","author":"S Weidinger","year":"2018","unstructured":"Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4:1.","journal-title":"Nat Rev Dis Primers"},{"key":"1504_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1600-065X.2011.01029.x","volume":"242","author":"C Ober","year":"2011","unstructured":"Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev. 2011;242:10\u201330.","journal-title":"Immunol Rev"},{"key":"1504_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.immuni.2015.03.014","volume":"42","author":"T Kobayashi","year":"2015","unstructured":"Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756\u201366.","journal-title":"Immunity"},{"key":"1504_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","volume":"26","author":"JA Geoghegan","year":"2018","unstructured":"Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018;26:484\u201397.","journal-title":"Trends Microbiol"},{"key":"1504_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41579-022-00686-0","volume":"20","author":"EA Masters","year":"2022","unstructured":"Masters EA, Ricciardi BF, Bentley KLM, Moriarty TF, Schwarz EM, Muthukrishnan G. Skeletal infections: microbial pathogenesis, immunity and clinical management. Nat Rev Microbiol. 2022;20:385\u2013400.","journal-title":"Nat Rev Microbiol"},{"key":"1504_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12895-019-0098-0","volume":"20","author":"JT Masuka","year":"2020","unstructured":"Masuka JT, Troisi K, Mkhize Z. Osteomyelitis complicating secondarily infected atopic eczema: two case reports and a narrative literature review. BMC Dermatol. 2020;20:2.","journal-title":"BMC Dermatol"},{"key":"1504_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.anai.2017.08.289","volume":"119","author":"R Chopra","year":"2017","unstructured":"Chopra R, Vakharia PP, Sacotte R, Silverberg JI. Efficacy of bleach baths in reducing severity of atopic dermatitis: A systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;119:435\u201340.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1504_CR11","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.jaci.2019.01.009","volume":"143","author":"Y Sawada","year":"2019","unstructured":"Sawada Y, Tong Y, Barangi M, Hata T, Williams MR, Nakatsuji T, et al. Dilute bleach baths used for treatment of atopic dermatitis are not antimicrobial in vitro. J Allergy Clin Immunol. 2019;143:1946\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"1504_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","volume":"27","author":"T Nakatsuji","year":"2021","unstructured":"Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, et al. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med. 2021;27:700\u20139.","journal-title":"Nat Med"},{"key":"1504_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","volume":"138","author":"T Werfel","year":"2016","unstructured":"Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"1504_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/febs.13904","volume":"284","author":"O Uluckan","year":"2017","unstructured":"Uluckan O, Wagner EF. Chronic systemic inflammation originating from epithelial tissues. FEBS J. 2017;284:505\u201316.","journal-title":"FEBS J"},{"key":"1504_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jaci.2014.10.043","volume":"135","author":"NK Garg","year":"2015","unstructured":"Garg NK, Silverberg JI. Eczema is associated with osteoporosis and fractures in adults: a US population-based study. J Allergy Clin Immunol. 2015;135:1085\u20137.e2.","journal-title":"J Allergy Clin Immunol"},{"key":"1504_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaad.2018.05.026","volume":"80","author":"MS Shaheen","year":"2019","unstructured":"Shaheen MS, Silverberg JI. Atopic dermatitis is associated with osteoporosis and osteopenia in older adults. J Am Acad Dermatol. 2019;80:550\u20131.","journal-title":"J Am Acad Dermatol"},{"key":"1504_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4939-6786-5_8","volume":"1559","author":"V Moosbrugger-Martinz","year":"2017","unstructured":"Moosbrugger-Martinz V, Schmuth M, Dubrac S. A mouse model for atopic dermatitis using topical application of vitamin D3 or of its analog MC903. Methods Mol Biol. 2017;1559:91\u2013106.","journal-title":"Methods Mol Biol"},{"key":"1504_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112494","volume":"42","author":"T Nakatsuji","year":"2023","unstructured":"Nakatsuji T, Brinton SL, Cavagnero KJ, O\u2019Neill AM, Chen Y, Dokoshi T, et al. Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus. Cell Rep. 2023;42:112494.","journal-title":"Cell Rep"},{"key":"1504_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature03963","volume":"437","author":"R Zenz","year":"2005","unstructured":"Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D, et al. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 2005;437:369\u201375.","journal-title":"Nature"},{"key":"1504_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/ar2338","volume":"10","author":"R Zenz","year":"2008","unstructured":"Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, et al. Activator protein 1 (Fos\/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008;10:201.","journal-title":"Arthritis Res Ther"},{"key":"1504_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.celrep.2019.09.042","volume":"29","author":"O Uluckan","year":"2019","unstructured":"Uluckan O, Jimenez M, Roediger B, Schnabl J, Diez-Cordova LT, Troule K, et al. Cutaneous immune cell-microbiota interactions are controlled by epidermal JunB\/AP-1. Cell Rep. 2019;29:844\u201359.e3.","journal-title":"Cell Rep"},{"key":"1504_CR22","doi-asserted-by":"crossref","unstructured":"Sukseree S, Bakiri L, Irigoyen MP, Uluckan O, Petzelbauer P, Wagner EF. Sequestosome 1\/p62 enhances chronic skin inflammation. J Allergy Clin Immunol. 2021;147:2386\u201393.e4.","DOI":"10.1016\/j.jaci.2021.02.028"},{"key":"1504_CR23","doi-asserted-by":"publisher","first-page":"330ra37","DOI":"10.1126\/scitranslmed.aad8996","volume":"8","author":"O Uluckan","year":"2016","unstructured":"Uluckan O, Jimenez M, Karbach S, Jeschke A, Grana O, Keller J, et al. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med. 2016;8:330ra37.","journal-title":"Sci Transl Med"},{"key":"1504_CR24","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ncb1761","volume":"10","author":"A Meixner","year":"2008","unstructured":"Meixner A, Zenz R, Schonthaler HB, Kenner L, Scheuch H, Penninger JM, et al. Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat Cell Biol. 2008;10:1003\u201311.","journal-title":"Nat Cell Biol"},{"key":"1504_CR25","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1073\/pnas.0910371106","volume":"106","author":"P Pflegerl","year":"2009","unstructured":"Pflegerl P, Vesely P, Hantusch B, Schlederer M, Zenz R, Janig E, et al. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci USA. 2009;106:20423\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1504_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","volume":"39","author":"HB Schonthaler","year":"2013","unstructured":"Schonthaler HB, Guinea-Viniegra J, Wculek SK, Ruppen I, Ximenez-Embun P, Guio-Carrion A, et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 2013;39:1171\u201381.","journal-title":"Immunity"},{"key":"1504_CR27","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1136\/annrheumdis-2022-222229","volume":"81","author":"LF Mellor","year":"2022","unstructured":"Mellor LF, Gago-Lopez N, Bakiri L, Schmidt FN, Busse B, Rauber S, et al. Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease. Ann Rheum Dis. 2022;81:1400\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1504_CR28","doi-asserted-by":"crossref","unstructured":"Manils J, Webb LV, Howes A, Janzen J, Boeing S, Bowcock AM, et al. CARD14(E138A) signalling in keratinocytes induces TNF-dependent skin and systemic inflammation. Elife. 2020;9:e56720.","DOI":"10.7554\/eLife.56720"},{"key":"1504_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/emboj.2012.309","volume":"32","author":"B Petersen","year":"2013","unstructured":"Petersen B, Wolf M, Austermann J, van Lent P, Foell D, Ahlmann M, et al. The alarmin Mrp8\/14 as regulator of the adaptive immune response during allergic contact dermatitis. EMBO J. 2013;32:100\u201311.","journal-title":"EMBO J"},{"key":"1504_CR30","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1172\/JCI89867","volume":"128","author":"T Vogl","year":"2018","unstructured":"Vogl T, Stratis A, Wixler V, Voller T, Thurainayagam S, Jorch SK, et al. Autoinhibitory regulation of S100A8\/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest. 2018;128:1852\u201366.","journal-title":"J Clin Invest"},{"key":"1504_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113006","volume":"42","author":"M von Wulffen","year":"2023","unstructured":"von Wulffen M, Luehrmann V, Robeck S, Russo A, Fischer-Riepe L, van den Bosch M, et al. S100A8\/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Rep. 2023;42:113006.","journal-title":"Cell Rep"},{"key":"1504_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax5849","volume":"6","author":"F Benhadou","year":"2020","unstructured":"Benhadou F, Glitzner E, Brisebarre A, Swedlund B, Song Y, Dubois C, et al. Epidermal autonomous VEGFA\/Flt1\/Nrp1 functions mediate psoriasis-like disease. Sci Adv. 2020;6:eaax5849.","journal-title":"Sci Adv"},{"key":"1504_CR33","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.jid.2023.02.026","volume":"143","author":"BM Silva de Melo","year":"2023","unstructured":"Silva de Melo BM, Veras FP, Zwicky P, Lima D, Ingelfinger F, Martins TV, et al. S100A9 drives the chronification of psoriasiform inflammation by inducing IL-23\/Type 3 immunity. J Invest Dermatol. 2023;143:1678\u201388.e8.","journal-title":"J Invest Dermatol"},{"key":"1504_CR34","doi-asserted-by":"publisher","first-page":"e2201505","DOI":"10.1002\/advs.202201505","volume":"9","author":"A Russo","year":"2022","unstructured":"Russo A, Schurmann H, Brandt M, Scholz K, Matos ALL, Grill D, et al. Alarming and Calming: Opposing Roles of S100A8\/S100A9 Dimers and Tetramers on Monocytes. Adv Sci. 2022;9:e2201505.","journal-title":"Adv Sci"},{"key":"1504_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4049\/jimmunol.2000087","volume":"206","author":"J Defrene","year":"2021","unstructured":"Defrene J, Berrazouane S, Esparza N, Page N, Cote MF, Gobeil S, et al. Deletion of S100a8 and S100a9 enhances skin hyperplasia and promotes the Th17 response in imiquimod-induced psoriasis. J Immunol. 2021;206:505\u201314.","journal-title":"J Immunol"},{"key":"1504_CR36","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in Inflammation. Front Immunol. 2018;9:1298.","journal-title":"Front Immunol"},{"key":"1504_CR37","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","volume":"70","author":"A Jukic","year":"2021","unstructured":"Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: from biomarker to biological function. Gut. 2021;70:1978\u201388.","journal-title":"Gut"},{"key":"1504_CR38","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jaci.2020.03.041","volume":"146","author":"TB Rojahn","year":"2020","unstructured":"Rojahn TB, Vorstandlechner V, Krausgruber T, Bauer WM, Alkon N, Bangert C, et al. Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis. J Allergy Clin Immunol. 2020;146:1056\u201369.","journal-title":"J Allergy Clin Immunol"},{"key":"1504_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cell.2004.10.010","volume":"119","author":"E Passegue","year":"2004","unstructured":"Passegue E, Wagner EF, Weissman IL. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell. 2004;119:431\u201343.","journal-title":"Cell"},{"key":"1504_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0140-6736(90)93237-J","volume":"336","author":"M Steinbakk","year":"1990","unstructured":"Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990;336:763\u20135.","journal-title":"Lancet"},{"key":"1504_CR41","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41584-018-0058-9","volume":"14","author":"J Austermann","year":"2018","unstructured":"Austermann J, Spiekermann C, Roth J. S100 proteins in rheumatic diseases. Nat Rev Rheumatol. 2018;14:528\u201341.","journal-title":"Nat Rev Rheumatol"},{"key":"1504_CR42","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1128\/IAI.00420-13","volume":"81","author":"TE Kehl-Fie","year":"2013","unstructured":"Kehl-Fie TE, Zhang Y, Moore JL, Farrand AJ, Hood MI, Rathi S, et al. MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun. 2013;81:3395\u2013405.","journal-title":"Infect Immun"},{"key":"1504_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature25177","volume":"553","author":"YE Chen","year":"2018","unstructured":"Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018;553:427\u201336.","journal-title":"Nature"},{"key":"1504_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.1260144","volume":"346","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Segre JA. Dialogue between skin microbiota and immunity. Science. 2014;346:954\u20139.","journal-title":"Science"},{"key":"1504_CR45","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1096\/fj.13-247460","volume":"28","author":"K De Filippo","year":"2014","unstructured":"De Filippo K, Neill DR, Mathies M, Bangert M, McNeill E, Kadioglu A, et al. A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia. FASEB J. 2014;28:3600\u20138.","journal-title":"FASEB J"},{"key":"1504_CR46","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","volume":"384","author":"S Stander","year":"2021","unstructured":"Stander S. Atopic dermatitis. N Engl J Med. 2021;384:1136\u201343.","journal-title":"N Engl J Med"},{"key":"1504_CR47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1365-2133.2006.07410.x","volume":"155","author":"JQ Gong","year":"2006","unstructured":"Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155:680\u20137.","journal-title":"Br J Dermatol"},{"key":"1504_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.chom.2017.10.015","volume":"22","author":"MR Williams","year":"2017","unstructured":"Williams MR, Nakatsuji T, Gallo RL. Staphylococcus aureus: master manipulator of the skin. Cell Host Microbe. 2017;22:579\u201381.","journal-title":"Cell Host Microbe"},{"key":"1504_CR49","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1016\/j.cell.2023.10.019","volume":"186","author":"L Deng","year":"2023","unstructured":"Deng L, Costa F, Blake KJ, Choi S, Chandrabalan A, Yousuf MS, et al. S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis. Cell. 2023;186:5375\u201393.e25.","journal-title":"Cell"},{"key":"1504_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.immuni.2023.03.015","volume":"56","author":"EB Kopp","year":"2023","unstructured":"Kopp EB, Agaronyan K, Licona-Limon I, Nish SA, Medzhitov R. Modes of type 2 immune response initiation. Immunity. 2023;56:687\u201394.","journal-title":"Immunity"},{"key":"1504_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.chom.2013.05.003","volume":"13","author":"JE Cassat","year":"2013","unstructured":"Cassat JE, Hammer ND, Campbell JP, Benson MA, Perrien DS, Mrak LN, et al. A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis. Cell Host Microbe. 2013;13:759\u201372.","journal-title":"Cell Host Microbe"},{"key":"1504_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/pde.12665","volume":"32","author":"D Patel","year":"2015","unstructured":"Patel D, Jahnke MN. Serious complications from Staphylococcal aureus in atopic dermatitis. Pediatr Dermatol. 2015;32:792\u20136.","journal-title":"Pediatr Dermatol"},{"key":"1504_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archderm.1988.01670030084028","volume":"124","author":"S Boiko","year":"1988","unstructured":"Boiko S, Kaufman RA, Lucky AW. Osteomyelitis of the distal phalanges in three children with severe atopic dermatitis. Arch Dermatol. 1988;124:418\u201323.","journal-title":"Arch Dermatol"},{"key":"1504_CR54","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/dvdy.22709","volume":"240","author":"JR Baker","year":"2011","unstructured":"Baker JR, Jeffery R, May RD, Mathies M, Spencer-Dene B, Poulsom R, et al. Distinct roles for S100a8 in early embryo development and in the maternal deciduum. Dev Dyn. 2011;240:2194\u2013203.","journal-title":"Dev Dyn"},{"key":"1504_CR55","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jlb.66.4.549","volume":"66","author":"RJ Passey","year":"1999","unstructured":"Passey RJ, Xu K, Hume DA, Geczy CL. S100A8: emerging functions and regulation. J Leukoc Biol. 1999;66:549\u201356.","journal-title":"J Leukoc Biol"},{"key":"1504_CR56","doi-asserted-by":"publisher","first-page":"e0221528","DOI":"10.1371\/journal.pone.0221528","volume":"14","author":"A Cesaro","year":"2019","unstructured":"Cesaro A, Defrene J, Lachhab A, Page N, Tardif MR, Al-Shami A, et al. Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice. PLoS ONE. 2019;14:e0221528.","journal-title":"PLoS ONE"},{"key":"1504_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","volume":"143","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E, Bissonnette R, Ungar B, Suarez-Farinas M, Ardeleanu M, Esaki H, et al. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143:155\u201372.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01504-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01504-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:23:53Z","timestamp":1759764233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01504-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1504"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01504-9","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with local\/institutional guidelines and European regulations. Mouse experiments were approved under license 66.009\/171-V\/3b\/2018, with an extension 2024-0.859.437, and performed following MUW and European guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}